PHARMACIE NOUVELLE CABESTAING : revenue, balance sheet and financial ratios

PHARMACIE NOUVELLE CABESTAING is a French company founded 15 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in COURCELLES-LES-LENS (62970), this company of category PME shows in 2022 a revenue of 1.9 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE NOUVELLE CABESTAING (SIREN 529975831)
Indicator 2024 2023 2022 2021 2020 2018 2017 2016 2015 2014
Revenue N/C N/C 1 873 651 € N/C N/C N/C 1 485 485 € 1 563 081 € 1 824 670 € 1 588 635 €
Net income 54 267 € 76 596 € 82 364 € 119 174 € 103 519 € 92 867 € 39 737 € 75 495 € 72 845 € 65 247 €
EBITDA N/C N/C 104 367 € N/C N/C N/C 47 521 € 99 502 € 88 340 € 90 883 €
Net margin N/C N/C 4.4% N/C N/C N/C 2.7% 4.8% 4.0% 4.1%

Revenue and income statement

In 2024, PHARMACIE NOUVELLE CABESTAING generates positive net income of 54 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2014-2024: 65 k€ -> 54 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

54 267 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 10%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 72%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

10.172%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

72.434%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

27.6%

Solvency indicators evolution
PHARMACIE NOUVELLE CABESTAING

Sector positioning

Debt ratio
10.17 2024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Excellent

In 2024, the debt ratio of PHARMACIE NOUVELLE CABEST... (10.17) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
72.43% 2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Excellent

In 2024, the financial autonomy of PHARMACIE NOUVELLE CABEST... (72.4%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.

Repayment capacity
2.44 years 2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Good

In 2022, the repayment capacity of PHARMACIE NOUVELLE CABEST... (2.44) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 168.85. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

168.853

Liquidity indicators evolution
PHARMACIE NOUVELLE CABESTAING

Sector positioning

Liquidity ratio
168.85 2024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Average +13 pts over 3 years

In 2024, the liquidity ratio of PHARMACIE NOUVELLE CABEST... (168.85) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Interest coverage
6.55x 2022
2022
Q1: 0.74x
Med: 2.5x
Q3: 5.15x
Excellent

In 2022, the interest coverage of PHARMACIE NOUVELLE CABEST... (6.5x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
PHARMACIE NOUVELLE CABESTAING

Positioning of PHARMACIE NOUVELLE CABESTAING in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of PHARMACIE NOUVELLE CABESTAING is estimated at 757 607 € (range 527 585€ - 1 133 424€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
527k€ 757k€ 1133k€
757 607 € Range: 527 585€ - 1 133 424€
NAF 5 année 2024

Valuation method used

Net Income Multiple
54 267 € × 14.0x = 757 607 €
Range: 527 586€ - 1 133 424€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE NOUVELLE CABESTAING with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMACIE NOUVELLE CABESTAING

What is the revenue of PHARMACIE NOUVELLE CABESTAING ?

The revenue of PHARMACIE NOUVELLE CABESTAING in 2022 is 1.9 M€.

Is PHARMACIE NOUVELLE CABESTAING profitable?

Yes, PHARMACIE NOUVELLE CABESTAING generated a net profit of 54 k€ in 2024.

Where is the headquarters of PHARMACIE NOUVELLE CABESTAING ?

The headquarters of PHARMACIE NOUVELLE CABESTAING is located in COURCELLES-LES-LENS (62970), in the department Pas-de-Calais.

Where to find the tax return of PHARMACIE NOUVELLE CABESTAING ?

The tax return of PHARMACIE NOUVELLE CABESTAING is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE NOUVELLE CABESTAING operate?

PHARMACIE NOUVELLE CABESTAING operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.